Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.

PloS one - 1 Jan 2014

Shen Yuanming, Zhou Jiansong, Li Yang, Ye Feng, Wan Xiaoyun, Lu Weiguo, Xie Xing, Cheng Xiaodong

Abstract excerpt

Acquired chemo-resistance is one of the key causal factors in cancer death. Emerging evidences suggest that miRNA and epithelial-mesenchymal transition play critical roles in the chemo-resistance in cancers. Here, we showed the association of paclitaxel-resistance with miR-375 over-expression and epithelial-mesenchymal transition inducement in cervical cancer. Using different cervical cancer cell models, we found...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherins
Share to Drug Resistance, Neoplasm
Share to Epithelial-Mesenchymal Transition

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Feedback, Physiological

Share to MicroRNAs

Share to Paclitaxel

Share to Up-Regulation

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25330011
DOI: 10.1371/journal.pone.0109299
PMCID: PMC4199595

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miR-375 mediated acquired chemo-resistance in cervical cancer by facilitating EMT.PMID 25330011Read ↗

Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial–mesenchymal transition processSemantic proximity Read ↗

Association of the Epithelial–Mesenchymal Transition (EMT) with Cisplatin ResistanceSemantic proximity Read ↗

Signaling Pathways in Cervical Cancer Chemoresistance: Are microRNAs and Long-Noncoding RNAs the Main Culprits?Semantic proximity Read ↗

MiR-375 promotes cisplatin sensitivity of lung adenocarcinomaSemantic proximity Read ↗

Vimentin Promotes the Aggressiveness of Triple Negative Breast Cancer Cells Surviving Chemotherapeutic TreatmentSemantic proximity Read ↗

Chemoresistance to 5-fluorouracil induces epithelial–mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cellsSemantic proximity Read ↗

Transferrin receptor modulated by microRNA-497-5p suppresses cervical cancer cell malignant phenotypes.Semantic proximity Read ↗

CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cellsSemantic proximity Read ↗

TALEN-mediated Nanog disruption results in less invasiveness, more chemosensitivity and reversal of EMT in Hela cells.Semantic proximity Read ↗

Epithelial‐to‐mesenchymal transition is involved in BCNU resistance in human glioma cellsSemantic proximity Read ↗

SPP1 knockdown inhibits invasion, migration and paclitaxel-induced Epithelial-Mesenchymal Transition in Cervical Cancer Cells through the TGF-β/Akt/Snail pathwaySemantic proximity Read ↗

Epithelial-to-Mesenchymal Transition in Paclitaxel-Resistant Ovarian Cancer Cells Is Downregulated by Luteolin.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.